ATE335495T1 - Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungen - Google Patents
Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungenInfo
- Publication number
- ATE335495T1 ATE335495T1 AT02022633T AT02022633T ATE335495T1 AT E335495 T1 ATE335495 T1 AT E335495T1 AT 02022633 T AT02022633 T AT 02022633T AT 02022633 T AT02022633 T AT 02022633T AT E335495 T1 ATE335495 T1 AT E335495T1
- Authority
- AT
- Austria
- Prior art keywords
- porous spherical
- liver
- treatment
- pharmaceutical preparation
- carbon particles
- Prior art date
Links
- 208000017169 kidney disease Diseases 0.000 title abstract 3
- 208000019423 liver disease Diseases 0.000 title abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 title 1
- 210000004185 liver Anatomy 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000003575 carbonaceous material Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000011148 porous material Substances 0.000 abstract 2
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001553 hepatotropic effect Effects 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02022633A EP1407772B9 (de) | 2002-10-09 | 2002-10-09 | Pharmazeutische Zubereitung enthaltend poröse sphärische kohlenstoffhaltige Teilchen und deren Verwendung zur Behandlung von Leber- und Nierenerkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE335495T1 true ATE335495T1 (de) | 2006-09-15 |
Family
ID=32010951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02022633T ATE335495T1 (de) | 2002-10-09 | 2002-10-09 | Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungen |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1407772B9 (de) |
| AT (1) | ATE335495T1 (de) |
| DE (1) | DE60213819T2 (de) |
| DK (1) | DK1407772T3 (de) |
| ES (1) | ES2269580T3 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI370013B (en) * | 2004-04-02 | 2012-08-11 | Kureha Corp | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
| TWI370012B (en) | 2004-04-02 | 2012-08-11 | Kureha Corp | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
| GB201204696D0 (en) | 2012-03-16 | 2012-05-02 | Ucl Business Plc | Therapy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS565313A (en) * | 1979-06-26 | 1981-01-20 | Kureha Chem Ind Co Ltd | Detoxificating spherical active carbon and preparing the same |
| US4761284A (en) * | 1977-12-27 | 1988-08-02 | Kureha Kagaku Kogy Kabushiki Kaisha | Antidote including activated carbon particles |
| JPS5673542A (en) * | 1979-11-22 | 1981-06-18 | Kureha Chem Ind Co Ltd | Adsorbent |
| JP3518878B2 (ja) * | 1992-10-29 | 2004-04-12 | 呉羽化学工業株式会社 | 抗ネフローゼ症候群剤 |
| CA2162086A1 (en) * | 1994-11-15 | 1996-05-16 | Michihito Ise | Agent for reducing nephrotoxicity due to medicine |
| JP3522708B2 (ja) * | 2001-04-11 | 2004-04-26 | 呉羽化学工業株式会社 | 経口投与用吸着剤 |
-
2002
- 2002-10-09 DK DK02022633T patent/DK1407772T3/da active
- 2002-10-09 AT AT02022633T patent/ATE335495T1/de active
- 2002-10-09 ES ES02022633T patent/ES2269580T3/es not_active Expired - Lifetime
- 2002-10-09 DE DE60213819T patent/DE60213819T2/de not_active Expired - Lifetime
- 2002-10-09 EP EP02022633A patent/EP1407772B9/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60213819T2 (de) | 2007-08-09 |
| DK1407772T3 (da) | 2006-12-11 |
| EP1407772B9 (de) | 2007-02-21 |
| DE60213819D1 (de) | 2006-09-21 |
| EP1407772A1 (de) | 2004-04-14 |
| ES2269580T3 (es) | 2007-04-01 |
| EP1407772B1 (de) | 2006-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60220849D1 (de) | Adsorptionsmittel in oraler Darreichungsform | |
| Zare et al. | Remediation of pharmaceuticals from contaminated water by molecularly imprinted polymers: a review | |
| ATE388716T1 (de) | Absorbens zur oralen aufnahme, und mittel zur behandlung oder vorbeugung von nieren- oder lebererkrankungen | |
| EP0393723B1 (de) | Funktionelles Papier und seine Verwendung als Deodorant, Filtermedium oder Adsorptionsmittel | |
| CA2111398A1 (en) | Upset resistant macroporous carbon-inorganic oxide composite support for bioremediation | |
| RU2005116680A (ru) | Адсорбент для перорального введения и средство для лечения или тпредупреждения заболевания почек или печени | |
| CA2343123A1 (en) | Active substance concentrate with formoterol, suitable for storage | |
| FR2780052B1 (fr) | Agglomerats a base de charbon actif leur procede de preparation et leur utilisation comme agents d'adsorption | |
| CA2150184A1 (en) | Pharmaceutical composition for the treatment of inflammatory bowel diseases | |
| RU2005116683A (ru) | Адсорбент для перорального введения | |
| CN103025316A (zh) | 硅藻土在医药工业中的用途 | |
| ATE335495T1 (de) | Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungen | |
| JP2000041670A (ja) | 脱臭システムおよび脱臭装置 | |
| WO2002080885B1 (en) | Detoxification and decontamination using nanotechnology therapy | |
| JPS62178642A (ja) | 建材 | |
| TW200500084A (en) | Adsorbent for oral administration and pharmaceutical composition, and method of manufacturing absorbent for oral administration | |
| JPS63274434A (ja) | 脱臭方法 | |
| JPS63242261A (ja) | 消臭・吸湿マツト | |
| CN100357364C (zh) | 具空气净化功能的多层复合型纳米涂层材料及用途 | |
| Nikolaev et al. | Physical and biological modification of carbonic sorbents | |
| JPH0217293U (de) | ||
| KR200143612Y1 (ko) | 방사물질이 함유된 벽지 | |
| Sergienko et al. | Electrochemical methods of detoxification for medical use | |
| KR200297892Y1 (ko) | 조화 | |
| KR200177962Y1 (ko) | 숯을 내장한 판재(板材) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1407772 Country of ref document: EP |